FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2120284003> ?p ?o ?g. }

• W2120284003 endingPage "895" @default.
• W2120284003 startingPage "883" @default.
• W2120284003 abstract "Human urinary bladder cancer is the fifth most common cancer, with a worldwide estimate of about two million patients. Recurrence after complete transurethral prostatic resection is the most important problem in therapy. Combination therapy is a new approach in the treatment of cancers that do not respond to current therapies. These therapies have many advantages over conventional therapies, such as fewer side-effects and greater efficiency. Research efforts using natural compounds for the elimination or growth suppression of the cancer arise from studies on methylsulfonylmethane (MSM). MSM is a natural sulfur compound with no side-effects. AG490 is a tyrosine kinase inhibitor that has been extensively used for inhibiting Jak2 in vitro and in vivo. In our study, the combinatorial effect of these two agents on human bladder cancer cell lines and xenografts was analyzed. We observed that the combination of AG490 and MSM inhibited cancer cell viability and cell migration in vitro. This combination inhibited VEGF mRNA expression in bladder cancer cell lines. In vivo experiments showed that oral administration of AG490 and MSM combination significantly inhibited the growth of tumor xenografts in mice. Our study clearly demonstrates that the predominant effect of this combination is the reduction of signaling molecules including STAT3, STAT5b, IGF-1R, VEGF and VEGF-R2 which are involved in the growth, progression and metastasis of human bladder cancer. The anti-metastatic ability of this drug combination is confirmed using metastatic animal models. Therefore, this combination could have the effect of genesistasis and powerful anticancer effects against bladder cancer." @default.
• W2120284003 created "2016-06-24" @default.
• W2120284003 creator A5003623368 @default.
• W2120284003 creator A5011161325 @default.
• W2120284003 creator A5011965794 @default.
• W2120284003 creator A5021985685 @default.
• W2120284003 creator A5022104668 @default.
• W2120284003 creator A5025545040 @default.
• W2120284003 creator A5029512205 @default.
• W2120284003 creator A5037166452 @default.
• W2120284003 creator A5039817301 @default.
• W2120284003 creator A5041086457 @default.
• W2120284003 creator A5041334048 @default.
• W2120284003 creator A5044892795 @default.
• W2120284003 creator A5058538828 @default.
• W2120284003 creator A5058647906 @default.
• W2120284003 creator A5075155781 @default.
• W2120284003 date "2014-01-08" @default.
• W2120284003 modified "2023-09-25" @default.
• W2120284003 title "Combination of AG490, a Jak2 inhibitor, and methylsulfonylmethane synergistically suppresses bladder tumor growth via the Jak2/STAT3 pathway" @default.
• W2120284003 cites W1514100422 @default.
• W2120284003 cites W1547275201 @default.
• W2120284003 cites W1968365367 @default.
• W2120284003 cites W1973009607 @default.
• W2120284003 cites W1973569615 @default.
• W2120284003 cites W1978347836 @default.
• W2120284003 cites W1979107436 @default.
• W2120284003 cites W1980469692 @default.
• W2120284003 cites W1991498850 @default.
• W2120284003 cites W2003589417 @default.
• W2120284003 cites W2007897471 @default.
• W2120284003 cites W2010394923 @default.
• W2120284003 cites W2018561776 @default.
• W2120284003 cites W2021800932 @default.
• W2120284003 cites W2022091445 @default.
• W2120284003 cites W2022137114 @default.
• W2120284003 cites W2027382240 @default.
• W2120284003 cites W2031243902 @default.
• W2120284003 cites W2054529141 @default.
• W2120284003 cites W2056961869 @default.
• W2120284003 cites W2061870936 @default.
• W2120284003 cites W2064117666 @default.
• W2120284003 cites W2073283919 @default.
• W2120284003 cites W2081414779 @default.
• W2120284003 cites W2083714459 @default.
• W2120284003 cites W2083802827 @default.
• W2120284003 cites W2084993188 @default.
• W2120284003 cites W2086715846 @default.
• W2120284003 cites W2087963453 @default.
• W2120284003 cites W2103079856 @default.
• W2120284003 cites W2106787323 @default.
• W2120284003 cites W2112824485 @default.
• W2120284003 cites W2123373938 @default.
• W2120284003 cites W2126359852 @default.
• W2120284003 cites W2127048642 @default.
• W2120284003 cites W2129927432 @default.
• W2120284003 cites W2133579100 @default.
• W2120284003 cites W2138578836 @default.
• W2120284003 cites W2142233318 @default.
• W2120284003 cites W2160239020 @default.
• W2120284003 cites W2163069245 @default.
• W2120284003 cites W2186227808 @default.
• W2120284003 cites W2265786825 @default.
• W2120284003 cites W2336213711 @default.
• W2120284003 cites W2793323124 @default.
• W2120284003 doi "https://doi.org/10.3892/ijo.2014.2250" @default.
• W2120284003 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24402583" @default.
• W2120284003 hasPublicationYear "2014" @default.
• W2120284003 type Work @default.
• W2120284003 sameAs 2120284003 @default.
• W2120284003 citedByCount "42" @default.
• W2120284003 countsByYear W21202840032015 @default.
• W2120284003 countsByYear W21202840032016 @default.
• W2120284003 countsByYear W21202840032017 @default.
• W2120284003 countsByYear W21202840032018 @default.
• W2120284003 countsByYear W21202840032019 @default.
• W2120284003 countsByYear W21202840032020 @default.
• W2120284003 countsByYear W21202840032021 @default.
• W2120284003 countsByYear W21202840032022 @default.
• W2120284003 countsByYear W21202840032023 @default.
• W2120284003 crossrefType "journal-article" @default.
• W2120284003 hasAuthorship W2120284003A5003623368 @default.
• W2120284003 hasAuthorship W2120284003A5011161325 @default.
• W2120284003 hasAuthorship W2120284003A5011965794 @default.
• W2120284003 hasAuthorship W2120284003A5021985685 @default.
• W2120284003 hasAuthorship W2120284003A5022104668 @default.
• W2120284003 hasAuthorship W2120284003A5025545040 @default.
• W2120284003 hasAuthorship W2120284003A5029512205 @default.
• W2120284003 hasAuthorship W2120284003A5037166452 @default.
• W2120284003 hasAuthorship W2120284003A5039817301 @default.
• W2120284003 hasAuthorship W2120284003A5041086457 @default.
• W2120284003 hasAuthorship W2120284003A5041334048 @default.
• W2120284003 hasAuthorship W2120284003A5044892795 @default.
• W2120284003 hasAuthorship W2120284003A5058538828 @default.
• W2120284003 hasAuthorship W2120284003A5058647906 @default.
• W2120284003 hasAuthorship W2120284003A5075155781 @default.
• W2120284003 hasBestOaLocation W21202840031 @default.
• W2120284003 hasConcept C121608353 @default.

• next